Stopping the Pharmaceutical Industry from Keeping drugs Expensive (SPIKE) Act of 2019
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in senate (Feb 13, 2019)
Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act of 2019
This bill requires manufacturers of drugs with specified percentage increases in their wholesale costs to submit to the Centers for Medicare & Medicaid Services (CMS) written justification for certain increases in drug prices. The CMS shall publish each submission, together with an easily understandable summary, on its website. Certain proprietary information may be excluded from publication, as specified by the bill.
A manufacturer that does not comply with the bill's requirements shall be subject to civil monetary penalties.
What just happenedFeb 13, 2019
Read twice and referred to the Committee on Finance.
Who’s behind it
- Introduced in SenateFeb 13, 2019
- Feb 13, 2019IntroReferral
Read twice and referred to the Committee on Finance.
Finance Committee - Feb 13, 2019IntroReferral10000
Introduced in Senate